Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
- 31 May 2004
- journal article
- clinical trial
- Published by Elsevier in Oral Oncology
- Vol. 40 (5) , 525-531
- https://doi.org/10.1016/j.oraloncology.2003.10.010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinomaCancer, 2001
- Final report of a phase II evaluation of paclitaxel in patients with advanced squamous cell carcinoma of the head and neckCancer, 1998
- Single agent paclitaxel in advanced squamous cell head and neck carcinomaEuropean Journal Of Cancer, 1996
- Chemotherapy in locally advanced head and neck cancer: a critical reappraisalCancer Treatment Reviews, 1995
- Chemotherapy advances in head and neck oncologySeminars in Surgical Oncology, 1995
- Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Head and Neck CancerNew England Journal of Medicine, 1993
- Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.Journal of Clinical Oncology, 1992
- Sequences of taxol and cisplatin: a phase I and pharmacologic study.Journal of Clinical Oncology, 1991
- Reporting results of cancer treatmentCancer, 1981